Introduction
============

Cancer is a major life-threatening disease worldwide. GLOBOCAN 2012 estimated that approximately 14.1 million patients were newly diagnosed with cancer and 8.2 million people died from cancer \[[@b1-crt-2016-089]\]. The global burden of cancer is expected to grow rapidly due to population growth and aging \[[@b2-crt-2016-089]\].

In Korea, cancer accounts for one in four deaths (27.6%) and more than 200,000 new cancer cases were diagnosed in 2012 \[[@b3-crt-2016-089]\]. Cancer incidence and deaths are expected to increase with increasing population aging and westernized lifestyles \[[@b4-crt-2016-089]\]. In addition, the economic burden of cancer in Korea increased about 1.8-fold, from \$11,424 to \$20,858 million, between 2000 and 2010 \[[@b5-crt-2016-089]\].

In this context, cancer statistics are the most important indicator to assess the national cancer burden and establish cancer prevention and control strategies. This article aims to provide nationwide cancer statistics including cancer incidence, survival, prevalence, and mortality in 2013.

Materials and Methods
=====================

1. Data sources
---------------

The Korea Central Cancer Registry (KCCR) was established by the Ministry of Health and Welfare in 1980. Until 1998, the KCCR registered cancer cases from hospitals in order to determine cancer incidence, with increasing coverage. Since 1999, the KCCR has collected cancer incidence data nationwide by integrating a hospital-based KCCR database with data from regional cancer registry programs. The KCCR currently provides the nationwide cancer incidence, survival, and prevalence statistics annually. KCCR has been described in more detail elsewhere \[[@b6-crt-2016-089]\].

The KCCR built the Korea National Cancer Incidence Database (KNCI DB) from hospitals, 11 population-based registries, site-specific cancer registries, and additional medical chart review. The KNCI DB includes patient case information including age, sex, region, date of birth, date of diagnosis, primary cancer site, histological type, most valid diagnostic method, and stage. The completeness of cancer incidence data for 2013 was estimated to be 97.8% based on the method proposed by Ajiki et al. \[[@b7-crt-2016-089]\]. Mid-year population and cancer mortality data from 1983 to 2013 were obtained from Statistics Korea (<http://kosis.kr>) \[[@b8-crt-2016-089]\]. To ascertain vital status and calculate survival and prevalence, the KNCI DB was linked to mortality data.

2. Classification
-----------------

All incident cancer cases were collected and registered according to the International Classification of Diseases for Oncology, 3rd edition \[[@b9-crt-2016-089]\]. The all cancer cases were reported according to the International Classification of Diseases, 10th edition (ICD-10) \[[@b10-crt-2016-089]\] and categorized into 24 cancer types.

3. Statistical analyses
-----------------------

Rates were expressed as crude and age-standardized rates (CR and ASR, respectively) per 100,000 individuals. The crude rate was calculated as the total number of incidence/mortality cases divided by the mid-year population of the specified years. The sum of the expected age-specific rates was obtained by multiplying the age-specific incidence rates among study population by the proportion of population in the corresponding age-specific groups among standard population. Next, the age-standardized incidence rates per 100,000 people were calculated as the sums of the expected age-specific rates divided by the sum of the standard population \[[@b11-crt-2016-089]\]. We used Segi's world standard population to calculate the age-standardized rates \[[@b12-crt-2016-089]\]. Age-specific rates were also calculated for given age groups. The cumulative risk of developing cancer from birth to life expectancy were calculated using cumulative rates; that is, the sum of the age-specific rates from birth to life expectancy, as follows \[[@b13-crt-2016-089]\]:

$$\operatorname{Cumulative\ risk\ of\ developing\ cancer\ from\ birth\ to\ life\ expectancy} = 100 \times \left( 1 - e^{-}\frac{cumulative~rate}{100} \right)$$

Trends in incidence/mortality rates were summarized as annual percentage change (APC). APC is the average percentage change of rates and is calculated as follows \[[@b11-crt-2016-089]\]:

$$APC = \frac{R_{y + 1} - R_{y}}{R_{y}} \times 100 = \left( e^{b1} - 1 \right) \times 100$$

, where log(*R*~y~)=*b*~0~+*b*~1~y,

log(*R*~y~) is the natural log transformed age standardized rates.

y=year, *b*~0~=intercept, *b*~1~=slope

The survival duration for each cancer case was determined as the interval between the date of initial diagnosis and the date of death, date of loss of follow-up, or closing date for follow-up (December 31, 2014). Relative survival rates were calculated using the Ederer II method \[[@b14-crt-2016-089]\] with some minor corrections, based on an algorithm by Paul Dickman \[[@b15-crt-2016-089]\]. The 5-year relative survival rates were calculated as the ratios of the observed survival of the cancer patients to the expected survival of the general population, which was derived from the standard life table provided by Statistics Korea. Trends in 5-year relative survival rates were evaluated as percentage differences in 5-year relative survival rates from 1993-1995 and 2009-2013.

Prevalent cases were defined as the number of cancer patients alive on January 1, 2014 among all cancer patients diagnosed between 1999 and 2013. Limited-duration prevalences were calculated using SEER^\*^Stat software to calculate 1-, 3-, and 5-year prevalent cases.

P-values less than 0.05 were considered statistically significant. SEER^\*^Stat 8.2.1 (National Cancer Institute, Bethesda, MD) and SAS 9.3 (SAS Institute Inc., Cary, NC) were used to calculate the incidence, mortality, survival, and prevalence and to perform the statistical analyses.

Selected Findings
=================

1. Incidence
------------

A total of 225,343 cases were newly diagnosed with cancer during the study period ([Table 1](#t1-crt-2016-089){ref-type="table"}). Of these cases, 113,744 (50.5%) were men and 111,599 cases (49.5%) were women. Thyroid cancer was the most commonly diagnosed cancer in 2013, and followed by stomach, colorectal, lung, and breast cancer in 2013. The overall cumulative risk of developing cancer from birth to life expectancy was 36.6%. However, the cumulative risk of developing cancer from birth to life expectancy was higher in men (38.3%) than in women (35.0%).

The total CR and ASR for overall cancer incidence in 2013 were 445.7 and 290.5 per 100,000, respectively ([Table 2](#t2-crt-2016-089){ref-type="table"}). According to sex, CRs for all sites combined were 449.9 per 100,000 in men and 441.5 per 100,000 in women. The ASRs were 316.5 and 281.8 per 100,000 in men and women, respectively. Stomach cancer (CR, 80.2 per 100,000) was the most common cancer in men, followed by colorectal (CR, 65.6 per 100,000), lung (CR, 64.0 per 100,000), liver (CR, 47.9 per 100,000), and prostate cancer (CR, 37.6 per 100,000). These five cancers accounted for 65.6% of newly diagnosed cancer in men during the study period. In contrast, thyroid cancer (CR, 134.9 per 100,000) was the most common cancer among women, followed by breast (CR, 68.2 per 100,000), colorectal (CR, 43.6 per 100,000), stomach (CR, 39.2 per 100,000), and lung cancer (CR, 27.7 per 100,000). These five cancers accounted for 71.0% of cases in women.

2. Mortality
------------

In 2013, cancer was the most common leading cause of death in Korea ([Table 3](#t3-crt-2016-089){ref-type="table"}). The total number of deaths from cancer was 75,334 in 2013, accounting for 28.3% of all deaths ([Table 3](#t3-crt-2016-089){ref-type="table"}). According to sex, 62.5% and 37.5% of cancer deaths occurred in men and women, respectively ([Table 1](#t1-crt-2016-089){ref-type="table"}).

The total CR and ASR for cancer deaths were 149.0 and 87.9 per 100,000, respectively, in 2013 ([Table 4](#t4-crt-2016-089){ref-type="table"}). The total CR and ASR for cancer deaths per 100,000 were higher among men (ASR, 130.1) than in women (ASR, 57.5).

According to the cancer sites, lung cancer (CR, 49.5 per 100,000) was the leading cause of death in men, followed by liver (CR, 33.3 per 100,000), stomach (CR, 23.7 per 100,000), colorectal (CR, 18.4 per 100,000), and pancreatic cancer (CR, 10.3 per 100,000). The top five causes of deaths from cancer in women included lung (CR, 18.4 per 100,000), colorectal (CR, 14.0 per 100,000), stomach (CR, 12.6 per 100,000), liver (CR, 11.8 per 100,000), and breast cancer (CR, 8.8 per 100,000)

3. Trends in cancer incidence and mortality rates
-------------------------------------------------

The trends in overall cancer incidence and mortality rates by sex are shown in [Fig. 1](#f1-crt-2016-089){ref-type="fig"}. The ASR for all-cancer incidence increased 3.1% annually from 1999 to 2013 ([Table 5](#t5-crt-2016-089){ref-type="table"}, [Fig. 1](#f1-crt-2016-089){ref-type="fig"}). However, in recent years, ASR for all-cancer incidence has decreased slightly, from 303.8 per 100,000 in 2011 to 290.5 per 100,000 in 2013 (APC, --2.1%). In contrast, ASR for all-cancer mortality has decreased 2.7% annually from 2002 to 2013 ([Fig. 1](#f1-crt-2016-089){ref-type="fig"}).

The ASR for all-cancer incidence in women (APC, 5.1%; 95% confidence interval \[CI\], 4.6 to 5.6) has increased more rapidly than that in men (APC, 1.3%; 95% CI, 1.0 to 1.6) ([Tables 6](#t6-crt-2016-089){ref-type="table"} and [7](#t7-crt-2016-089){ref-type="table"}) since 1999, whereas ASR for all-cancer mortality in men (APC, --3.1%; 95% CI, --3.3 to --2.8) has decreased faster than that in women (APC, --2.2%; 95% CI, --2.5 to --1.9) since 2002 ([Fig. 1](#f1-crt-2016-089){ref-type="fig"}).

4. Trends in cancer incidence and mortality rates by common cancer sites
------------------------------------------------------------------------

Between 1999 and 2013, ASR for thyroid cancer incidence has been most notably increased in both men (APC, 22.7%) and women (APC, 20.6%) ([Tables 6](#t6-crt-2016-089){ref-type="table"} and [7](#t7-crt-2016-089){ref-type="table"}). Among men, the age-standardized incidence rates of prostate (APC, 10.7%) and colorectal cancer (APC, 5.0%) have increased from 1999 to 2013, while the age-standardized incidence rates of liver (APC, --2.2%), lung (APC, --1.0%), and stomach cancer (APC, --0.8%) have decreased from 1999 to 2013 ([Table 6](#t6-crt-2016-089){ref-type="table"}, [Fig. 2](#f2-crt-2016-089){ref-type="fig"}). Among women, the age-standardized incidence rates of breast (APC, 5.9%), colorectal (APC, 3.7%), and lung (APC, 1.7%) have increased from 1999 to 2013 ([Table 7](#t7-crt-2016-089){ref-type="table"}). However, the age-standardized incidence rates of cervical (APC, --3.9%), liver (APC, --1.8%), and stomach cancer (APC, --0.7%) in women have decreased from 1999 to 2013.

The age-standardized mortality rate of stomach cancer has decreased continuously in both sexes ([Fig. 3](#f3-crt-2016-089){ref-type="fig"}). Although the age-standardized mortality rate of colorectal cancer increased from 1983 to 2003, the mortality rate of colorectal cancer has leveled off since 2003 in men. For women, the age-standardized mortality of colorectal cancer increased from 1983 to 2004, but the mortality rate has subsequently decreased. For both sexes, the age-standardized mortality of lung cancer increased from 1983 to 2002, and the mortality rates for lung cancer decreased. The mortality rates for uterine cancer in women and liver cancer in both sexes have continuously decreased since the mid-1990s. However, the breast cancer mortality rate in women and the prostate cancer mortality rate in men showed increasing trends during the observation period (1983-2013).

5. Age-specific incidence rates
-------------------------------

According to age group, leukemia was the most commonly diagnosed cancer among children between 0-14 years of age, while thyroid cancer was the most common cancer among adolescents and young adults between 15 and 34 years of age ([Table 8](#t8-crt-2016-089){ref-type="table"}). For men, the incidence rate of cancer increased with age ([Fig. 4A](#f4-crt-2016-089){ref-type="fig"}). Stomach cancer was the most commonly diagnosed cancer among men aged 35 and 64 years old, while lung cancer was the most common among elderly men aged ≥ 65 years. In contrast, thyroid cancer was most commonly diagnosed among women aged 35 and 64 years, while colorectal cancer was most common among elderly women aged ≥ 65 years. Thyroid and breast cancer showed inverted U-shaped incidence rates by age ([Fig. 4B](#f4-crt-2016-089){ref-type="fig"}).

6. Survival rates
-----------------

The 5-year relative survival rates for all cancer combined improved remarkably in both sexes, from 41.2% in 1993-1995 to 69.4% in 2009-2013 ([Table 9](#t9-crt-2016-089){ref-type="table"}, [Fig. 5A](#f5-crt-2016-089){ref-type="fig"}). After excluding thyroid cancer, the 5-year relative survival rates for all cancer still increased from 1993-1995 to 2009-2013 ([Fig. 5B](#f5-crt-2016-089){ref-type="fig"}).

The 5-year relative survival rate in 2009-2013 for all cancer combined was 61.0% in men and 77.7% in women, respectively. The 5-year relative survival rate for thyroid cancer was over 100%, while the 5-year relative survival rates for testis, prostate, and breast cancer were over 90% in 2009-2013 for both sexes, respectively. However, the 5-year relative survival rate for pancreatic cancer was only 9.4% in both sexes in 2009-2013.

When compared to the 5-year relative survival rate for 1993-1995, prostate cancer diagnosed from 2009 to 2013 showed the most outstanding improvement, followed by stomach cancer, leukemia, 'lip, oral cavity, and pharynx' and colorectal cancer in men. Among women, stomach cancer diagnosed during 2009-2013 showed the greatest improvement in 5-year relative survival rates compared to those between 1993 and 1995, followed by leukemia, non-Hodgkin's lymphoma, colorectal cancer, and kidney cancer.

7. Prevalence rates
-------------------

A total of 1,370,049 cancer prevalent cases were identified on January 1, 2014 ([Table 1](#t1-crt-2016-089){ref-type="table"}). Of these cases, 603,524 (44.1%) were men and 766,525 (55.9%) were women. The crude and age-standardized prevalence rates for cancer overall were 2,709.8 per 100,000 individuals and 1,772.4 per 100,000 individuals for both sexes, respectively, in 2013 ([Table 10](#t10-crt-2016-089){ref-type="table"}). Among men, the crude and age-standardized prevalence rates for cancer overall were 2,387.1 and 1,683.6 per 100,000 individuals, respectively. Among women the rates for cancer overall were 3,032.6 and 1,944.3 per 100,000 individuals, respectively.

The five most common cancers for men were stomach (CR, 589.0 per 100,000), colorectal (CR, 449.1 per 100,000), prostate (CR, 220.5 per 100,000), thyroid (CR, 194.3 per 100,000), and liver cancer (CR, 163.0 per 100,000). In contrast, thyroid cancer was most common in women (CR, 995.9 per 100,000), followed by breast (CR, 579.3 per 100,000), colorectal (CR, 302.8 per 100,000), stomach (CR, 298.4 per 100,000), and cervix uteri cancer (CR, 181.9 per 100,000).

Analysis of the time period after cancer diagnosis revealed that thyroid cancer (23.2%) was the most prevalent cancer within 2 years after cancer diagnosis, followed by stomach (13.9%) and colorectal cancer (13.3%) ([Fig. 6](#f6-crt-2016-089){ref-type="fig"}). Thyroid cancer (26.2%) was most prevalent for 2-5 years, followed by stomach (15.4%) and colorectal cancer (14.0%). After 5 years, stomach cancer (18.6%) was the most prevalent cancer, followed by thyroid (18.1%) and colorectal cancer (14.1%).
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###### 

Cancer incidence, deaths and prevalence by sex in Korea, 2013

  Site/Type                                                    New cases   Deaths    Prevalent cases^[a)](#tfn1-crt-2016-089){ref-type="table-fn"}^                                                    
  ------------------------------------------------------------ ----------- --------- ---------------------------------------------------------------- -------- -------- -------- ----------- --------- ---------
  All sites                                                    225,343     113,744   111,599                                                          75,334   47,079   28,255   1,370,049   603,524   766,525
  Lip, oral cavity, and pharynx                                3,041       2,181     860                                                              1,078    821      257      18,539      12,476    6,063
  Esophagus                                                    2,382       2,186     196                                                              1,448    1,320    128      8,090       7,321     769
  Stomach                                                      30,184      20,266    9,918                                                            9,180    5,995    3,185    224,352     148,926   75,426
  Colon and rectum                                             27,618      16,593    11,025                                                           8,199    4,659    3,540    190,094     113,547   76,547
  Liver                                                        16,192      12,105    4,087                                                            11,405   8,421    2,984    55,049      41,203    13,846
  Gallbladder^[b)](#tfn2-crt-2016-089){ref-type="table-fn"}^   5,283       2,707     2,576                                                            3,783    1,874    1,909    16,021      8,195     7,826
  Pancreas                                                     5,511       2,982     2,529                                                            4,831    2,615    2,216    7,757       4,185     3,572
  Larynx                                                       1,196       1,116     80                                                               403      369      34       9,149       8,592     557
  Lung                                                         23,177      16,171    7,006                                                            17,177   12,519   4,658    58,653      37,399    21,254
  Breast                                                       17,292      61        17,231                                                           2,244    13       2,231    147,012     596       146,416
  Cervix uteri                                                 3,633       \-        3,633                                                            892      \-       892      45,989      \-        45,989
  Corpus uteri                                                 2,212       \-        2,212                                                            248      \-       248      17,053      \-        17,053
  Ovary                                                        2,236       \-        2,236                                                            1,038    \-       1,038    15,362      \-        15,362
  Prostate                                                     9,515       9,515     \-                                                               1,629    1,629    \-       55,756      55,756    \-
  Testis                                                       254         254       \-                                                               19       19       \-       2,440       2,440     \-
  Kidney                                                       4,333       2,992     1,341                                                            937      664      273      29,069      19,621    9,448
  Bladder                                                      3,762       3,025     737                                                              1,280    975      305      27,440      22,360    5,080
  Brain and CNS                                                1,813       941       872                                                              1,196    625      571      9,302       4,828     4,474
  Thyroid                                                      42,541      8,454     34,087                                                           393      120      273      300,851     49,119    251,732
  Hodgkin lymphoma                                             262         169       93                                                               63       41       22       2,194       1,401     793
  Non-Hodgkin lymphoma                                         4,828       2,668     2,160                                                            1,581    929      652      29,347      15,797    13,550
  Multiple myeloma                                             1,327       694       633                                                              804      437      367      4,325       2,256     2,069
  Leukemia                                                     3,011       1,716     1,295                                                            1,593    945      648      16,309      9,002     7,307
  Other and ill-defined                                        13,740      6,948     6,792                                                            3,913    2,089    1,824    79,896      38,504    41,392

CNS, central nervous system.

Limited-duration prevalent cases on January 1, 2014. These are patients who were diagnosed between January 1, 1999 and December 31, 2013 and who were alive on January 1, 2014. Multiple primary cancer cases were counted multiple times,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Crude and age-standardized cancer incidence rates by sex in Korea, 2013

  Site/Type                                                    Crude incidence rate per 100,000   Age-standardized incidence rate per 100,000^[a)](#tfn3-crt-2016-089){ref-type="table-fn"}^                           
  ------------------------------------------------------------ ---------------------------------- -------------------------------------------------------------------------------------------- ------- ------- ------- -------
  All sites                                                    445.7                              449.9                                                                                        441.5   290.5   316.5   281.8
  Lip, oral cavity, and pharynx                                6.0                                8.6                                                                                          3.4     4.0     6.0     2.2
  Esophagus                                                    4.7                                8.6                                                                                          0.8     2.9     6.0     0.4
  Stomach                                                      59.7                               80.2                                                                                         39.2    37.4    55.3    22.4
  Colon and rectum                                             54.6                               65.6                                                                                         43.6    34.0    45.6    24.4
  Liver                                                        32.0                               47.9                                                                                         16.2    20.2    32.8    9.0
  Gallbladder^[b)](#tfn4-crt-2016-089){ref-type="table-fn"}^   10.4                               10.7                                                                                         10.2    6.1     7.4     5.0
  Pancreas                                                     10.9                               11.8                                                                                         10.0    6.6     8.2     5.2
  Larynx                                                       2.4                                4.4                                                                                          0.3     1.5     3.1     0.2
  Lung                                                         45.8                               64.0                                                                                         27.7    27.4    44.2    14.9
  Breast                                                       34.2                               0.2                                                                                          68.2    23.0    0.2     45.7
  Cervix uteri                                                 7.2                                \-                                                                                           14.4    4.8     \-      9.5
  Corpus uteri                                                 4.4                                \-                                                                                           8.8     2.9     \-      5.8
  Ovary                                                        4.4                                \-                                                                                           8.8     3.1     \-      6.0
  Prostate                                                     18.8                               37.6                                                                                         \-      11.4    26.2    \-
  Testis                                                       0.5                                1.0                                                                                          \-      0.5     1.0     \-
  Kidney                                                       8.6                                11.8                                                                                         5.3     5.7     8.3     3.4
  Bladder                                                      7.4                                12.0                                                                                         2.9     4.4     8.3     1.4
  Brain and CNS                                                3.6                                3.7                                                                                          3.4     2.9     3.2     2.7
  Thyroid                                                      84.1                               33.4                                                                                         134.9   60.1    24.0    96.6
  Hodgkin lymphoma                                             0.5                                0.7                                                                                          0.4     0.4     0.6     0.3
  Non-Hodgkin lymphoma                                         9.5                                10.6                                                                                         8.5     6.7     8.0     5.6
  Multiple myeloma                                             2.6                                2.7                                                                                          2.5     1.6     1.9     1.4
  Leukemia                                                     6.0                                6.8                                                                                          5.1     5.0     6.0     4.2
  Other and ill-defined                                        27.2                               27.5                                                                                         26.9    17.8    20.5    15.6

CNS, central nervous system.

Age-adjusted using the world standard population,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

The top 10 leading causes of death in Korea, 2013

  Rank   Cause of death                       No. of deaths   Percentage of all deaths   Age-standardized death rate per 100,000^[a)](#tfn5-crt-2016-089){ref-type="table-fn"}^
  ------ ------------------------------------ --------------- -------------------------- ----------------------------------------------------------------------------------------
         All causes                           266,257         100.0                      309.4
  1      Cancer                               75,334          28.3                       87.9
  2      Cerebrovascular disease              25,447          9.6                        27.0
  3      Heart disease                        25,365          9.5                        27.9
  4      Intentional self-harm (suicide)      14,427          5.4                        20.3
  5      Diabetes mellitus                    10,888          4.1                        11.6
  6      Pneumonia                            10,809          4.1                        11.2
  7      Chronic lower respiratory diseases   7,074           2.7                        7.3
  8      Disease of liver                     6,665           2.5                        8.3
  9      Transport accidents                  6,028           2.3                        8.7
  10     Hypertensive diseases                4,732           1.8                        4.9
         Others                               79,488          29.9                       94.4

Source: Mortality Data, 2013, Statistics Korea \[[@b8-crt-2016-089]\].

Age-adjusted using the world standard population.

###### 

Crude and age-standardized cancer mortality rates by sex in Korea, 2013

  Site/Type                                                    Crude mortality rate per 100,000   Age-standardized mortality rate per 100,000^[a)](#tfn6-crt-2016-089){ref-type="table-fn"}^                          
  ------------------------------------------------------------ ---------------------------------- -------------------------------------------------------------------------------------------- ------- ------ ------- ------
  All sites                                                    149.0                              186.2                                                                                        111.8   87.9   130.1   57.5
  Lip, oral cavity, and pharynx                                2.1                                3.2                                                                                          1.0     1.3    2.3     0.5
  Esophagus                                                    2.9                                5.2                                                                                          0.5     1.7    3.6     0.3
  Stomach                                                      18.2                               23.7                                                                                         12.6    10.5   16.4    6.1
  Colon and rectum                                             16.2                               18.4                                                                                         14.0    9.3    12.9    6.7
  Liver                                                        22.6                               33.3                                                                                         11.8    13.8   22.9    6.1
  Gallbladder^[b)](#tfn7-crt-2016-089){ref-type="table-fn"}^   7.5                                7.4                                                                                          7.6     4.2    5.2     3.5
  Pancreas                                                     9.6                                10.3                                                                                         8.8     5.6    7.2     4.4
  Larynx                                                       0.8                                1.5                                                                                          0.1     0.4    1.0     0.1
  Lung                                                         34.0                               49.5                                                                                         18.4    19.3   34.0    8.8
  Breast                                                       4.4                                0.1                                                                                          8.8     2.9    0.0     5.6
  Cervix uteri                                                 1.8                                \-                                                                                           3.5     1.1    \-      1.9
  Corpus uteri                                                 0.5                                \-                                                                                           1.0     0.3    \-      0.6
  Ovary                                                        2.1                                \-                                                                                           4.1     1.3    \-      2.4
  Prostate                                                     3.2                                6.4                                                                                          \-      1.7    4.8     \-
  Testis                                                       0.0                                0.1                                                                                          \-      0.0    0.1     \-
  Kidney                                                       1.9                                2.6                                                                                          1.1     1.1    1.8     0.5
  Bladder                                                      2.5                                3.9                                                                                          1.2     1.4    2.8     0.5
  Brain and CNS                                                2.4                                2.5                                                                                          2.3     1.7    2.0     1.5
  Thyroid                                                      0.8                                0.5                                                                                          1.1     0.4    0.3     0.5
  Hodgkin lymphoma                                             0.1                                0.2                                                                                          0.1     0.1    0.1     0.1
  Non-Hodgkin lymphoma                                         3.1                                3.7                                                                                          2.6     1.9    2.6     1.3
  Multiple myeloma                                             1.6                                1.7                                                                                          1.5     0.9    1.2     0.8
  Leukemia                                                     3.2                                3.7                                                                                          2.6     2.2    2.9     1.6
  Other and ill-defined                                        7.7                                8.3                                                                                          7.2     4.7    6.0     3.8

CNS, central nervous system.

Age-adjusted using the world standard population,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Trends in cancer incidence rates for both sexes from 1999 to 2013 in Korea

  Site/Type                                                    Year    APC                                                                                                             
  ------------------------------------------------------------ ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------------------------------------------------------
  All sites                                                    210.5   205.1   216.7   220.1   227.9   235.1   247.9   252.2   263.5   276.1   286.9   293.5   303.8   301.7   290.5   3.1^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^
  Lip, oral cavity, and pharynx                                3.6     4.4     3.6     3.7     3.8     3.8     3.8     3.8     3.9     4.0     3.8     4.0     4.1     4.0     4.0     0.4
  Esophagus                                                    4.1     3.7     3.9     3.8     3.6     3.6     3.5     3.4     3.3     3.3     3.1     3.1     3.0     3.0     2.9     --2.2^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^
  Stomach                                                      43.6    42.3    44.0    43.6    43.3    41.2    44.4    42.8    41.8    42.6    43.4    42.5    42.8    40.1    37.4    -0.6
  Colon and rectum                                             20.4    21.0    22.9    24.7    26.9    28.6    31.0    32.5    33.8    34.9    36.9    36.9    38.3    37.7    34.0    4.6^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^
  Liver                                                        27.9    26.7    27.3    26.5    25.7    25.6    25.8    24.6    24.4    24.1    23.5    22.8    22.5    21.2    20.2    --2.0^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^
  Gallbladder^[b)](#tfn9-crt-2016-089){ref-type="table-fn"}^   6.5     6.4     6.7     6.7     6.7     6.9     7.1     6.6     6.6     6.4     6.8     6.6     6.4     6.3     6.1     --0.3
  Pancreas                                                     5.6     5.5     5.5     5.8     5.9     6.0     6.3     6.2     6.3     6.4     6.3     6.4     6.7     6.8     6.6     1.5^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^
  Larynx                                                       2.3     2.2     2.4     2.2     2.1     1.9     2.0     1.8     1.8     1.7     1.7     1.6     1.5     1.4     1.5     --3.5^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^
  Lung                                                         28.5    27.7    28.3    28.5    27.9    28.8    29.0    28.7    28.4    28.2    28.3    28.6    28.7    27.7    27.4    --0.1
  Breast                                                       10.7    10.8    12.7    13.9    14.3    15.0    16.3    17.0    18.1    18.9    19.7    20.7    22.3    22.7    23.0    5.8^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^
  Cervix uteri                                                 8.5     7.9     8.3     7.7     7.4     6.9     6.5     6.4     5.7     5.9     5.5     5.6     5.2     4.9     4.8     --4.1^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^
  Corpus uteri                                                 1.4     1.3     1.5     1.7     1.9     1.9     2.0     2.1     2.2     2.4     2.6     2.6     2.7     2.7     2.9     5.6^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^
  Ovary                                                        2.7     2.5     2.5     2.6     2.7     2.7     2.8     2.8     3.1     2.9     2.8     3.0     3.0     3.1     3.1     1.4^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^
  Prostate                                                     3.1     2.7     3.6     3.9     4.8     6.0     6.3     7.3     8.6     9.8     10.6    11.0    11.9    11.7    11.4    12.0^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^
  Testis                                                       0.3     0.3     0.3     0.3     0.3     0.3     0.3     0.4     0.4     0.4     0.4     0.4     0.5     0.5     0.5     4.6^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^
  Kidney                                                       3.0     2.9     3.3     3.4     3.5     3.7     4.1     4.4     4.8     5.1     5.2     5.3     5.6     5.6     5.7     5.5^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^
  Bladder                                                      4.6     4.6     4.9     4.7     5.1     5.1     5.1     4.9     5.0     4.8     4.6     4.7     4.7     4.4     4.4     --0.5
  Brain and CNS                                                2.9     2.8     2.8     2.6     2.9     2.9     3.0     2.9     3.1     3.1     3.0     3.1     2.7     2.9     2.9     0.4
  Thyroid                                                      6.3     6.1     7.9     9.5     12.8    17.3    20.7    25.5    32.9    41.4    48.2    53.7    59.2    63.2    60.1    20.8^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^
  Hodgkin lymphoma                                             0.2     0.3     0.3     0.3     0.3     0.4     0.3     0.3     0.4     0.4     0.4     0.4     0.5     0.5     0.4     4.7^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^
  Non-Hodgkin lymphoma                                         4.5     4.2     4.5     4.6     5.0     5.3     5.3     5.5     5.6     5.7     6.2     6.2     6.6     6.7     6.7     3.5^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^
  Multiple myeloma                                             1.0     1.0     1.1     1.1     1.1     1.2     1.3     1.3     1.4     1.4     1.5     1.5     1.4     1.6     1.6     3.6^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^
  Leukemia                                                     4.7     4.3     4.7     4.8     4.8     4.8     4.7     4.9     4.9     5.0     5.1     5.0     5.2     5.0     5.0     0.9^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^
  Other and ill-defined                                        14.3    13.5    13.9    13.5    15.2    15.3    16.2    16.2    17.3    17.1    17.2    17.6    18.3    17.9    17.8    2.3^[a)](#tfn8-crt-2016-089){ref-type="table-fn"}^

APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system.

Significantly different from zero (p \< 0.05),

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Trends in cancer incidence rates in men from 1999 to 2013 in Korea

  Site/Type                                                     Year    APC                                                                                                             
  ------------------------------------------------------------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- -------------------------------------------------------
  All sites                                                     285.0   276.7   288.3   290.0   295.1   299.6   311.4   310.3   317.1   324.2   330.9   332.0   337.2   329.1   316.5   1.3^[a)](#tfn10-crt-2016-089){ref-type="table-fn"}^
  Lip, oral cavity, and pharynx                                 6.1     7.1     6.0     6.2     6.5     6.2     6.1     6.2     6.3     6.5     6.1     6.1     6.4     6.2     6.0     --0.2
  Esophagus                                                     8.8     8.0     8.3     8.2     7.7     7.7     7.6     7.2     7.0     7.0     6.6     6.5     6.3     6.1     6.0     --2.6^[a)](#tfn10-crt-2016-089){ref-type="table-fn"}^
  Stomach                                                       66.2    65.0    67.2    66.6    66.0    62.3    66.9    65.3    63.1    64.5    65.0    63.4    63.8    59.6    55.3    --0.8^[a)](#tfn10-crt-2016-089){ref-type="table-fn"}^
  Colon and rectum                                              26.2    27.2    29.6    32.9    35.3    38.0    41.2    43.3    45.3    47.0    50.0    50.1    52.0    50.4    45.6    5.0^[a)](#tfn10-crt-2016-089){ref-type="table-fn"}^
  Liver                                                         46.8    44.7    45.1    43.9    42.3    42.1    42.6    40.3    39.8    39.5    38.2    36.9    36.1    34.5    32.8    --2.2^[a)](#tfn10-crt-2016-089){ref-type="table-fn"}^
  Gallbladder^[b)](#tfn11-crt-2016-089){ref-type="table-fn"}^   8.1     7.8     8.2     8.1     7.8     8.4     8.7     8.1     7.9     7.6     8.1     8.2     7.7     7.6     7.4     --0.4
  Pancreas                                                      7.8     7.6     7.6     7.9     7.7     8.0     8.3     8.0     8.2     8.4     8.1     8.1     8.6     8.5     8.2     0.7^[a)](#tfn10-crt-2016-089){ref-type="table-fn"}^
  Larynx                                                        4.9     4.5     5.1     4.7     4.5     4.1     4.3     3.8     3.8     3.5     3.6     3.4     3.2     3.0     3.1     --3.6^[a)](#tfn10-crt-2016-089){ref-type="table-fn"}^
  Lung                                                          51.4    49.8    51.1    51.0    50.0    50.8    50.9    49.2    48.8    47.7    47.5    47.5    46.7    44.7    44.2    --1.0^[a)](#tfn10-crt-2016-089){ref-type="table-fn"}^
  Breast                                                        0.2     0.3     0.2     0.3     0.2     0.2     0.2     0.2     0.1     0.3     0.2     0.2     0.2     0.2     0.2     --1.4
  Prostate                                                      8.4     7.2     9.5     10.1    12.5    15.2    15.8    18.0    20.9    23.5    25.3    26.1    27.7    27.3    26.2    10.7^[a)](#tfn10-crt-2016-089){ref-type="table-fn"}^
  Testis                                                        0.6     0.5     0.6     0.6     0.6     0.6     0.6     0.7     0.7     0.7     0.8     0.8     0.9     0.9     1.0     4.5^[a)](#tfn10-crt-2016-089){ref-type="table-fn"}^
  Kidney                                                        4.5     4.4     4.9     5.0     5.2     5.5     6.0     6.5     7.1     7.5     7.6     8.0     8.1     8.3     8.3     5.2^[a)](#tfn10-crt-2016-089){ref-type="table-fn"}^
  Bladder                                                       9.0     9.0     9.4     9.0     9.7     9.8     9.8     9.6     9.5     9.2     8.7     8.9     8.9     8.3     8.3     --0.7^[a)](#tfn10-crt-2016-089){ref-type="table-fn"}^
  Brain and CNS                                                 3.2     3.1     3.1     2.9     3.3     3.3     3.3     3.2     3.4     3.4     3.5     3.5     3.0     3.3     3.2     0.5
  Thyroid                                                       2.1     1.9     2.4     2.7     3.7     4.8     5.9     7.5     10.0    13.3    15.6    18.6    20.4    23.3    24.0    22.7^[a)](#tfn10-crt-2016-089){ref-type="table-fn"}^
  Hodgkin lymphoma                                              0.4     0.4     0.4     0.3     0.4     0.5     0.4     0.4     0.5     0.5     0.5     0.6     0.6     0.6     0.6     3.9^[a)](#tfn10-crt-2016-089){ref-type="table-fn"}^
  Non-Hodgkin lymphoma                                          5.8     5.5     5.8     5.8     6.2     6.6     6.5     6.9     7.0     6.8     7.5     7.4     7.7     7.9     8.0     2.7^[a)](#tfn10-crt-2016-089){ref-type="table-fn"}^
  Multiple myeloma                                              1.2     1.3     1.4     1.4     1.4     1.4     1.6     1.5     1.6     1.7     1.9     1.8     1.8     2.0     1.9     3.3^[a)](#tfn10-crt-2016-089){ref-type="table-fn"}^
  Leukemia                                                      5.5     5.0     5.4     5.8     5.5     5.7     5.6     5.6     5.7     5.8     5.9     6.0     6.1     5.9     6.0     1.0^[a)](#tfn10-crt-2016-089){ref-type="table-fn"}^
  Other and ill-defined                                         17.9    16.5    16.8    16.5    18.5    18.3    19.3    18.9    20.4    19.8    20.0    19.9    20.9    20.3    20.5    1.6^[a)](#tfn10-crt-2016-089){ref-type="table-fn"}^

APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system.

Significantly different from zero (p \< 0.05),

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Trends in cancer incidence rates in women from 1999 to 2013 in Korea

  Site/Type                                                     Year    APC^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^                                                                                                           
  ------------------------------------------------------------- ------- ----------------------------------------------------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- -------------------------------------------------------
  All sites                                                     161.1   157.4                                                 169.0   174.6   184.6   193.9   208.1   216.7   232.5   249.9   263.9   275.5   290.3   292.9   281.8   5.1^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Lip, oral cavity, and pharynx                                 1.6     2.4                                                   1.7     1.7     1.7     1.9     1.9     1.8     1.9     1.9     1.8     2.2     2.1     2.0     2.2     1.3
  Esophagus                                                     0.6     0.6                                                   0.6     0.5     0.6     0.5     0.4     0.5     0.5     0.5     0.4     0.4     0.4     0.5     0.4     --2.2^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Stomach                                                       26.7    25.2                                                  26.2    26.3    25.9    24.7    26.8    25.1    24.8    25.1    25.8    25.4    25.3    23.7    22.4    --0.7^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Colon and rectum                                              16.4    16.4                                                  17.9    18.8    20.5    21.5    23.0    24.1    24.6    25.2    26.3    26.1    26.8    27.1    24.4    3.7^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Liver                                                         12.3    11.8                                                  12.2    11.8    11.5    11.3    11.4    11.1    11.1    10.7    10.6    10.4    10.5    9.6     9.0     --1.8^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Gallbladder^[b)](#tfn13-crt-2016-089){ref-type="table-fn"}^   5.3     5.5                                                   5.7     5.8     5.8     5.9     6.0     5.5     5.6     5.5     5.8     5.4     5.5     5.3     5.0     --0.5
  Pancreas                                                      4.0     4.0                                                   4.0     4.2     4.4     4.5     4.7     4.7     4.8     4.9     4.9     5.0     5.1     5.4     5.2     2.2^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Larynx                                                        0.4     0.3                                                   0.3     0.3     0.3     0.3     0.2     0.2     0.2     0.2     0.2     0.2     0.2     0.1     0.2     --7.0^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Lung                                                          12.4    12.5                                                  12.3    12.6    12.4    13.0    13.5    14.0    14.0    14.2    14.2    14.8    15.4    15.1    14.9    1.7^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Breast                                                        20.9    20.9                                                  24.7    27.2    27.9    29.4    32.1    33.3    35.7    37.3    38.8    40.8    44.1    44.9    45.7    5.9^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Cervix uteri                                                  16.3    15.1                                                  15.8    14.8    14.2    13.2    12.4    12.2    11.1    11.5    10.7    10.9    10.2    9.6     9.5     --3.9^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Corpus uteri                                                  2.8     2.6                                                   3.0     3.3     3.8     3.7     3.9     4.0     4.2     4.7     5.1     5.1     5.3     5.4     5.8     5.8^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Ovary                                                         5.0     4.8                                                   4.8     5.0     5.2     5.2     5.5     5.4     5.9     5.6     5.4     5.9     5.8     6.1     6.0     1.7^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Kidney                                                        1.7     1.8                                                   1.9     2.0     2.1     2.2     2.5     2.7     2.8     3.0     3.2     3.0     3.4     3.2     3.4     5.4^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Bladder                                                       1.6     1.6                                                   1.7     1.7     1.8     1.7     1.7     1.6     1.7     1.6     1.6     1.5     1.5     1.4     1.4     --1.1^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Brain and CNS                                                 2.6     2.5                                                   2.5     2.4     2.6     2.6     2.8     2.7     2.8     2.7     2.6     2.7     2.5     2.4     2.7     0.2
  Thyroid                                                       10.4    10.1                                                  13.2    16.2    21.9    29.6    35.4    43.4    55.7    69.6    80.8    89.0    98.3    103.5   96.6    20.6^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Hodgkin lymphoma                                              0.1     0.2                                                   0.2     0.2     0.2     0.2     0.2     0.3     0.3     0.3     0.3     0.3     0.4     0.3     0.3     5.7^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Non-Hodgkin lymphoma                                          3.4     3.2                                                   3.4     3.5     4.0     4.1     4.4     4.4     4.4     4.8     5.2     5.2     5.6     5.7     5.6     4.4^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Multiple myeloma                                              0.8     0.8                                                   0.9     0.8     1.0     1.0     1.2     1.1     1.2     1.2     1.2     1.3     1.1     1.4     1.4     4.1^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Leukemia                                                      3.9     3.8                                                   4.1     4.0     4.1     4.1     4.0     4.4     4.2     4.3     4.3     4.1     4.5     4.1     4.2     0.7^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^
  Other and ill-defined                                         11.8    11.5                                                  11.8    11.5    12.9    13.2    13.9    14.2    14.9    15.0    14.9    15.8    16.2    15.9    15.6    2.7^[a)](#tfn12-crt-2016-089){ref-type="table-fn"}^

APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system.

Significantly different from zero (p \< 0.05),

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

The five common sites of cancer incidence by age group and sex in Korea, 2013

  Rank         Age (yr)                                                                            
  ------------ ---------------------------- ---------------------------- ------------------------- --------------------------
  **Male**                                                                                         
   1           Leukemia (4.3)               Thyroid (17.7)               Stomach (88.3)            Lung (449.4)
   2           Non-Hodgkin lymphoma (2.4)   Leukemia (3.5)               Colon and rectum (69.5)   Stomach (396.3)
   3           Brain and CNS (2.0)          Colon and rectum (3.2)       Liver (62.4)              Colon and rectum (333.4)
   4           Liver (0.4)                  Non-Hodgkin lymphoma (3.0)   Thyroid (54.6)            Prostate (289.3)
   5           Testis (0.4)                 Stomach (2.3)                Lung (42.4)               Liver (192.1)
  **Female**                                                                                       
   1           Leukemia (3.4)               Thyroid (71.7)               Thyroid (228.2)           Colon and rectum (176.5)
   2           Brain and CNS (1.9)          Breast (10.6)                Breast (123.9)            Stomach (149.3)
   3           Non-Hodgkin lymphoma (1.1)   Cervix uteri (5.5)           Colon and rectum (40.8)   Lung (126.6)
   4           Thyroid (0.6)                Stomach (3.4)                Stomach (38.8)            Thyroid (92.7)
   5           Ovary (0.6)                  Ovary (3.1)                  Lung (21.7)               Liver (72.5)

CNS, central nervous system.

###### 

Trends in the 5-year relative survival rates (%) by year of diagnosis from 1993 to 2013 in Korea

  Site/Type                                                     Both sexes   Male   Female                                                                                   
  ------------------------------------------------------------- ------------ ------ -------- ------- ------ ------ ------ ------ ------- ------ ------ ------ ------ ------- -------
  All sites                                                     41.2         44.0   53.8     69.4    28.2   31.7   35.3   45.3   61.0    29.3   53.4   55.3   64.0   77.7    24.3
  Lip, oral cavity, and pharynx                                 41.1         46.7   54.2     63.1    22.0   35.8   41.1   49.4   59.3    23.5   58.1   63.8   67.7   73.0    14.9
  Esophagus                                                     12.7         15.2   21.2     33.4    20.7   11.8   14.3   20.5   33.1    21.3   23.7   24.2   29.6   36.1    12.4
  Stomach                                                       42.8         46.6   57.7     73.1    30.3   43.0   46.9   58.4   73.9    30.9   42.6   46.0   56.4   71.5    28.9
  Colon and rectum                                              54.8         58.0   66.6     75.6    20.8   55.3   59.0   68.5   77.5    22.2   54.2   56.8   64.2   72.6    18.4
  Liver                                                         10.7         13.2   20.2     31.4    20.7   9.9    12.9   20.2   31.6    21.7   13.6   14.2   20.4   30.8    17.2
  Gallbladder^[b)](#tfn15-crt-2016-089){ref-type="table-fn"}^   17.3         19.7   22.8     29.0    11.7   16.6   20.3   23.3   30.2    13.6   18.0   19.1   22.3   27.9    9.9
  Pancreas                                                      9.4          7.6    8.2      9.4     \-     8.8    7.3    8.2    9.2     0.4    10.1   8.1    8.1    9.7     --0.4
  Larynx                                                        59.7         62.3   66.2     73.1    13.4   60.2   62.8   66.8   73.5    13.3   55.4   57.8   58.2   66.9    11.5
  Lung                                                          11.3         12.7   16.2     23.5    12.2   10.4   11.6   15.0   20.5    10.1   14.2   16.2   19.7   30.6    16.4
  Breast                                                        77.9         83.2   88.5     91.5    13.6   75.1   85.6   87.0   91.6    16.5   78.0   83.2   88.5   91.5    13.5
  Cervix uteri                                                  77.5         80.0   81.3     80.1    2.6    \-     \-     \-     \-      \-     77.5   80.0   81.3   80.1    2.6
  Corpus uteri                                                  81.5         81.8   84.6     87.9    6.4    \-     \-     \-     \-      \-     81.5   81.8   84.6   87.9    6.4
  Ovary                                                         58.7         58.9   61.4     62.0    3.3    \-     \-     \-     \-      \-     58.7   58.9   61.4   62.0    3.3
  Prostate                                                      55.9         67.2   80.2     92.5    36.6   55.9   67.2   80.2   92.5    36.6   \-     \-     \-     \-      \-
  Testis                                                        85.4         90.4   90.6     94.9    9.5    85.4   90.4   90.6   94.9    9.5    \-     \-     \-     \-      \-
  Kidney                                                        62.0         66.1   73.4     80.8    18.8   60.8   64.4   72.8   80.5    19.7   64.5   69.7   74.5   81.6    17.1
  Bladder                                                       69.1         73.1   75.6     75.3    6.2    70.0   74.8   77.4   77.4    7.4    65.5   66.3   68.5   67.0    1.5
  Brain and CNS                                                 38.5         39.0   40.7     41.8    3.3    37.2   37.5   40.1   40.1    2.9    40.2   40.7   41.4   43.9    3.7
  Thyroid                                                       94.2         94.9   98.3     100.2   6.0    87.2   89.5   95.8   100.6   13.4   95.4   95.9   98.7   100.1   4.7
  Hodgkin lymphoma                                              68.0         71.2   76.6     78.2    10.2   67.6   68.1   74.6   78.6    11.0   68.6   77.4   80.7   77.5    8.9
  Non-Hodgkin lymphoma                                          46.6         50.8   60.0     68.4    21.8   45.3   48.9   58.1   66.6    21.3   48.7   53.5   62.4   70.5    21.8
  Multiple myeloma                                              22.1         19.8   29.3     38.9    16.8   21.1   17.8   29.6   37.6    16.5   23.3   22.1   29.0   40.5    17.2
  Leukemia                                                      26.5         33.3   41.8     49.7    23.2   26.2   32.3   41.7   49.7    23.5   26.8   34.6   42.0   49.6    22.8
  Other and ill-defined                                         42.1         45.9   55.9     68.1    26.0   37.4   42.4   52.2   64.6    27.2   47.4   50.0   60.0   71.7    24.3

CNS, central nervous system.

Percentage change in 5-year relative survival from 1993 to 1995 and 2009 to 2013,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Crude and age-standardized rates of cancer prevalence by sex on January 1, 2014 in Korea

  Site/Type                                                     Crude prevalence rate per 100,000^[a)](#tfn16-crt-2016-089){ref-type="table-fn"}^   Age-standardized prevalence rate per 100,000^[b)](#tfn17-crt-2016-089){ref-type="table-fn"}^                                 
  ------------------------------------------------------------- ----------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- --------- --------- --------- ---------
  All sites                                                     2,709.8                                                                             2,387.1                                                                                        3,032.6   1,772.4   1,683.6   1,944.3
  Lip, oral cavity, and pharynx                                 36.7                                                                                49.3                                                                                           24.0      24.3      34.7      15.3
  Esophagus                                                     16.0                                                                                29.0                                                                                           3.0       9.9       20.0      1.7
  Stomach                                                       443.7                                                                               589.0                                                                                          298.4     276.0     405.3     169.9
  Colon and rectum                                              376.0                                                                               449.1                                                                                          302.8     232.6     311.2     169.7
  Liver                                                         108.9                                                                               163.0                                                                                          54.8      71.1      113.2     33.2
  Gallbladder^[c)](#tfn18-crt-2016-089){ref-type="table-fn"}^   31.7                                                                                32.4                                                                                           31.0      19.0      22.3      16.5
  Pancreas                                                      15.3                                                                                16.6                                                                                           14.1      9.7       11.6      8.2
  Larynx                                                        18.1                                                                                34.0                                                                                           2.2       11.2      23.6      1.2
  Lung                                                          116.0                                                                               147.9                                                                                          84.1      71.8      102.7     48.1
  Breast                                                        290.8                                                                               2.4                                                                                            579.3     191.6     1.6       376.3
  Cervix uteri                                                  91.0                                                                                \-                                                                                             181.9     59.1      \-        115.0
  Corpus uteri                                                  33.7                                                                                \-                                                                                             67.5      22.6      \-        44.2
  Ovary                                                         30.4                                                                                \-                                                                                             60.8      21.6      \-        42.7
  Prostate                                                      110.3                                                                               220.5                                                                                          \-        63.1      152.1     \-
  Testis                                                        4.8                                                                                 9.7                                                                                            \-        4.4       8.6       \-
  Kidney                                                        57.5                                                                                77.6                                                                                           37.4      38.2      54.5      23.9
  Bladder                                                       54.3                                                                                88.4                                                                                           20.1      32.2      61.4      10.1
  Brain and CNS                                                 18.4                                                                                19.1                                                                                           17.7      15.9      16.9      14.8
  Thyroid                                                       595.0                                                                               194.3                                                                                          995.9     409.6     135.5     681.9
  Hodgkin lymphoma                                              4.3                                                                                 5.5                                                                                            3.1       3.6       4.6       2.7
  Non-Hodgkin lymphoma                                          58.0                                                                                62.5                                                                                           53.6      41.9      47.7      36.7
  Multiple myeloma                                              8.6                                                                                 8.9                                                                                            8.2       5.4       6.1       4.8
  Leukemia                                                      32.3                                                                                35.6                                                                                           28.9      30.6      34.2      27.0
  Other and ill-defined                                         158.0                                                                               152.3                                                                                          163.8     107.2     115.8     100.2

CNS, central nervous system.

Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2013 and who were alive on January 1, 2014. Multiple primary cancer cases were counted multiple times,

Age-adjusted using the world standard population,

Includes the gallbladder and other/unspecified parts of the biliary tract.
